CUSIP: 45719W106
What is CUSIP 45719W106?
CUSIP 45719W106 identifies IKT - INHIBIKASE THERAPEUTICS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 45719W106:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q3 | 0 | $0 | -$50,000 | 0 | |
| 2023 Q2 | 13,802 | $50,000 | -$3,102,999 | $3.62 | 1 |
| 2023 Q1 | 4,421,111 | $2,906,981 | +$2,027,723 | $0.66 | 17 |
| 2022 Q4 | 1,440,673 | $719,406 | -$603,994 | $0.50 | 19 |
| 2022 Q3 | 3,058,668 | $2,780,115 | -$196,503 | $0.91 | 23 |
| 2022 Q2 | 3,350,331 | $2,488,000 | -$1,415,548 | $0.74 | 20 |
| 2022 Q1 | 4,288,895 | $6,349,000 | -$566,079 | $1.48 | 24 |
| 2021 Q4 | 4,659,048 | $6,850,000 | +$170,486 | $1.47 | 23 |
| 2021 Q3 | 4,096,656 | $7,782,000 | +$464,572 | $1.90 | 19 |
| 2021 Q2 | 3,794,682 | $10,625,000 | +$6,720,225 | $2.80 | 13 |
| 2021 Q1 | 162,609 | $975,000 | +$150,000 | $5.98 | 8 |
| 2020 Q4 | 135,050 | $936,000 | +$936,000 | $7.00 | 5 |